Your session is about to expire
← Back to Search
Procedure
Performance and Acceptability of VSS-R
N/A
Waitlist Available
Research Sponsored by Abbott Medical Optics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
The results of this trial will demonstrate that AVSS software performs as intended and is acceptable in a clinical setting.
Eligible Conditions
- Refractive Errors
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Other study objectives
Loss of More Than 2 Lines Best Spectacle Corrected Visual Acuity (BSCVA)
Percent Manifest Refraction Spherical Equivalent Within 1.0D
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Refractive ErrorExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STAR S4IR LASIK with VSS-R ablation profile
2010
N/A
~150
Find a Location
Who is running the clinical trial?
Abbott Medical OpticsLead Sponsor
44 Previous Clinical Trials
6,643 Total Patients Enrolled
4 Trials studying Refractive Errors
581 Patients Enrolled for Refractive Errors
Nicholas Tarantino, ODStudy DirectorAbbott Medical Optics
7 Previous Clinical Trials
668 Total Patients Enrolled
2 Trials studying Refractive Errors
244 Patients Enrolled for Refractive Errors